M2 macrophage-derived exosomes promote angiogenesis and improve cardiac function after myocardial infarction

Hongzhou Guo1,2, Zeya Li1, Bin Xiao1

  • 1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Beijing, 100050, P. R. China.

Biology Direct
|June 5, 2024
PubMed
Abstract

Insights

M2 macrophage-derived exosomes (M2-exos) enhance cardiac repair after myocardial infarction (MI) by delivering miR-132-3p to endothelial cells, promoting angiogenesis and improving heart function.

Area of Science:

  • Cardiovascular Research
  • Cell Biology
  • Regenerative Medicine

Background:

  • Myocardial infarction (MI) is a leading global cause of death.
  • Intercellular communication's role in post-MI angiogenesis is not fully understood.

Purpose of the Study:

  • To investigate M2 macrophage-derived exosomes (M2-exos) and their mechanism in promoting angiogenesis after MI.
  • To elucidate the specific molecular pathways involved in M2-exo-mediated cardiac repair.

Main Methods:

  • M2-exos were isolated and administered intramyocardially in a mouse model of MI.
  • Endothelial cells (ECs) were treated with M2-exos in vitro to assess direct angiogenic effects.
  • The role of miR-132-3p and its target THBS1 in M2-exo function was analyzed.

Main Results:

  • M2-exos significantly improved cardiac function and reduced infarct size post-MI.
  • M2-exos demonstrated pro-angiogenic effects both in vivo and in vitro.
  • miR-132-3p within M2-exos was identified as crucial for cardioprotection, acting by downregulating THBS1 expression.

Conclusions:

  • M2-exos promote angiogenesis after MI via miR-132-3p transfer to ECs.
  • The M2-exo/miR-132-3p/THBS1 pathway is a key mechanism in cardiac repair.
  • These findings offer insights into exosome-based therapies for cardiovascular diseases.